Close this search box.


Press Release:

This was a really important win for the company when it happened. The press release details Factor Bioscience’s successful defense of its mRNA gene editing patent against a challenge mounted by a Russian counterpart.

Factor garnered excellent coverage in the industry media for this successful outcome., including mentions in several leading industry media. “The successful defense of this patent comes on the heels of our recent U.S. patent covering methods for producing gene-edited cells using mRNA encoding transcription activator-like effector nucleases (TALENs),” said Dr. Angel.